- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Mason-based medtech startup backed by Mark Cuban, CincyTech exits
Genetesis, a medical technology startup, is defunct following the sale of its business assets last summer to a large multibillion tech player.
Published on Feb. 8, 2026
Got story updates? Submit your updates here. ›
A Mason-based startup that had raised more than $40 million, including backing from Mark Cuban Cos. and CincyTech, has exited after 12 years. The company, Genetesis, sold its business assets last summer to a large multibillion-dollar tech player, though the terms and identity of the acquirer remain undisclosed. One of Genetesis' co-founders, Peeyush Shrivastava, has since taken on a new role as a principal at the O.H.I.O. Fund.
Why it matters
The exit of Genetesis, a medical technology startup, represents a significant milestone for the Cincinnati startup ecosystem, which has seen increased investment and activity in recent years. The acquisition by a large tech player also highlights the potential for local startups to attract national attention and be acquired by major industry players.
The details
Genetesis, a medical technology startup based in Mason, Ohio, had raised over $40 million in funding over 12 years, including investments from Mark Cuban Cos. and the local venture capital firm CincyTech. The company sold its business assets to a large, multibillion-dollar tech player last summer, though the specific terms and identity of the acquirer remain undisclosed. One of Genetesis' co-founders, Peeyush Shrivastava, has since taken on a new role as a principal at the O.H.I.O. Fund.
- Genetesis was founded over 12 years ago.
- The company sold its business assets last summer.
- Peeyush Shrivastava started his new role as a principal at the O.H.I.O. Fund on January 26, 2026.
The players
Genetesis
A medical technology startup based in Mason, Ohio, that had raised over $40 million in funding over 12 years, including investments from Mark Cuban Cos. and CincyTech.
Peeyush Shrivastava
A co-founder of Genetesis who has since taken on a new role as a principal at the O.H.I.O. Fund.
Mark Cuban Cos.
An investment firm founded by entrepreneur and 'Shark Tank' investor Mark Cuban that provided funding to Genetesis.
CincyTech
A local venture capital firm in Cincinnati that invested in Genetesis.
O.H.I.O. Fund
The fund that Peeyush Shrivastava has joined as a principal.
The takeaway
The exit of Genetesis, a medical technology startup backed by prominent investors like Mark Cuban, demonstrates the growing strength of the Cincinnati startup ecosystem and its ability to attract national attention and investment. The acquisition by a large tech player also highlights the potential for local startups to be acquired by major industry players, providing a successful exit for founders and investors.
